-
PNT Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
POINT Biopharma Global (PNT)
Company Profile
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 21.61 mm | 21.61 mm | 21.61 mm | 21.61 mm | 21.61 mm | 21.61 mm |
Cash burn (monthly) | 11.90 mm | 8.68 mm | 9.88 mm | (no burn) | 9.38 mm | (no burn) |
Cash used (since last report) | 202.98 mm | 148.13 mm | 168.51 mm | n/a | 160.01 mm | n/a |
Cash remaining | -181.37 mm | -126.53 mm | -146.90 mm | n/a | -138.40 mm | n/a |
Runway (months of cash) | -15.2 | -14.6 | -14.9 | n/a | -14.8 | n/a |
13F holders | Current |
---|---|
Total holders | 130 |
Opened positions | 14 |
Closed positions | 17 |
Increased positions | 51 |
Reduced positions | 38 |
13F shares | Current |
---|---|
Total value | 407.96 bn |
Total shares | 70.79 mm |
Total puts | 800.90 k |
Total calls | 228.70 k |
Total put/call ratio | 3.5 |
Largest owners | Shares | Value |
---|---|---|
BVF | 10.56 mm | $70.46 bn |
Biotechnology Value Fund L P | 9.18 mm | $0.00 |
BLK BlackRock | 6.64 mm | $44.26 bn |
Vanguard | 4.67 mm | $31.13 bn |
STT State Street | 3.53 mm | $23.53 bn |
Great Point Partners | 2.91 mm | $19.41 bn |
Deep Track Capital | 2.78 mm | $18.55 bn |
Boxer Capital | 2.50 mm | $16.68 bn |
BLVGF Bellevue | 2.35 mm | $15.68 bn |
Citadel Advisors | 2.16 mm | $14.39 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Dec 23 | Yael Margolin | Common Stock | Sale back to company | Dispose D | No | No | 0 | 1,710 | 0.00 | 0 |
27 Dec 23 | Yael Margolin | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 9.12 | 44,749 | 408.11 k | 0 |
27 Dec 23 | Yael Margolin | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.31 | 25,614 | 212.85 k | 0 |
27 Dec 23 | Yael Margolin | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.47 | 25,000 | 211.75 k | 0 |
27 Dec 23 | William L. Demers | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.78 | 131,355 | 890.59 k | 0 |
27 Dec 23 | William L. Demers | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.13 | 105,360 | 856.58 k | 0 |
27 Dec 23 | William L. Demers | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.47 | 16,767 | 142.02 k | 0 |
27 Dec 23 | William L. Demers | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.97 | 179,362 | 1.25 mm | 0 |
27 Dec 23 | Jessica D. Jensen | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.78 | 136,055 | 922.45 k | 0 |
27 Dec 23 | Jessica D. Jensen | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 7.91 | 13,766 | 108.89 k | 0 |